CMV-specific T-Cells for Treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: First application in Turkey

Celilova, SevilTöret, ErsinAdaklı Aksoy, BaşakOvalı, ErcümentBozkurt, Ceyhun2020-08-302020-08-302020Bao, Y., Huang, S., & Zhao, Z. (2020). Comparison of Different Culture Conditions for Mesenchymal Stem Cells from Human Umbilical Cord Wharton’s Jelly for Stem Cell Therapy. Turk J Hematol, 37, 57-76.1300-77771308-5263https://doi.org/10.4274/tjh.galenos.2019.2019.0293https://hdl.handle.net/20.500.12713/489Cytomegalovirus (CMV) infection is still a major complication after allogeneic hematopoietic stem cell transplantation (HSCT) [1,2]. Unfortunately, prolonged antiviral treatment of CMV infection causes a delayed CMV-specific immune reconstitution. At this point, adoptive immunotherapy by CMV-specific T-cells can control CMV infection or provide immune reconstructioneninfo:eu-repo/semantics/openAccessChildhoodHematopoietic Stem Cell TransplantCmvSpecific T-CellTherapyCMV-specific T-Cells for Treatment of CMV infection after hematopoietic stem cell transplantation in a pediatric case: First application in TurkeyLetter371656731718117WOS:0005148199000152-s2.0-85080844385Q410.4274/tjh.galenos.2019.2019.0293Q3365186